Want to join the conversation?
$EMR 3Q15 PR: Expects 2015 net sales to decline approx. 9%. Underlying sales are expected to be down approx. 2%, excluding negative currency translation of approximately 5% and 2% deduction from divestitures. Reported EPS is expected to be $3.97-4.07, including the power transmission solutions divestiture gain of $0.77 per share.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.